Quadrant Capital Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Quadrant Capital Group’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-404	Closed	-$4K	–	2501
2020 Q1	$4K	Sell	404 -1,401	-78%	-$19.6K	﹤0.01%	1741
2019 Q4	$29K	Hold	1,805	–	–	﹤0.01%	1583
2019 Q3	$29K	Buy	1,805 +1,239	+219%	+$17.1K	﹤0.01%	1462
2019 Q2	$7K	Hold	566	–	–	﹤0.01%	1925
2019 Q1	$9K	Hold	566	–	–	﹤0.01%	1727
2018 Q4	$7K	Hold	566	–	–	﹤0.01%	1540
2018 Q3	$9K	Hold	566	–	–	﹤0.01%	1359
2018 Q2	$7K	Hold	566	–	–	﹤0.01%	1463
2018 Q1	$7K	Buy	+566	New	+$6.89K	﹤0.01%	1444

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Quadrant Capital Group's OXFD Position: Q2 2020 in Review

Quadrant Capital Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2020, closing a stake of 404 shares — an estimated $4K sold.

Quadrant Capital Group first reported a position in OXFD in Q1 2018 and held it in 9 quarters. The position peaked at $29K in Q4 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q2 2020.

Quadrant Capital Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2020 after selling out during the quarter.
Quadrant Capital Group sold 404 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2020, an estimated $4K.
Quadrant Capital Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2018 and held it in 9 quarters.
Quadrant Capital Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $29K in Q4 2019.
65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2020.

Based on Quadrant Capital Group's 13F filing for Q2 2020, filed 13 Aug 2020.